MSeqDR Mitochondrial Disease Portal


 
*:HP: HPO terms, UMDF: 1= Disease, ND: NAMDC terms.
  Most Studied  CPEO, Complex I Deficiency, COXPD1, Leigh, LHON, MELAS, MERRF, Myopathy, SANDO
Term ID:4616
Name:Fanconi Anemia, Complementation Group D1
Definition:
Alternative IDs:OMIM:605724
ParentIDs:MESH:D005199
TreeNumbers:C15.378.071.085.080.280/C563980 |C15.378.190.196.080.280/C563980 |C16.320.077.280/C563980 |C18.452.284.280/C563980
Synonyms:FAD1 |FANCD1
Slim Mappings:Blood disease|Genetic disease (inborn)|Metabolic disease
Reference: MedGen: C563980
MeSH: C563980
OMIM: 605724;
MSeqDR LSDB:  
Genes: BRCA2;
Phenotypes
1 HP:0000007Autosomal recessive inheritance
2 HP:0004808Acute myeloid leukemiaHP:0040284
3 HP:0002023Anal atresiaHP:0040284
4 HP:0005528Bone marrow hypocellularity
5 HP:0000957Cafe-au-lait spotHP:0040284
6 HP:0003221Chromosomal breakage induced by crosslinking agents
7 HP:0001508Failure to thriveHP:0040284
8 HP:0001511Intrauterine growth retardationHP:0040284
9 HP:0000252MicrocephalyHP:0040284
10 HP:0004322Short stature
NAMDC:  Short stature (patient¡¯s height is below the 3rd percentile)
11 HP:0009778Short thumbHP:0040284
12 HP:0006727T-cell acute lymphoblastic leukemiasHP:0040284
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVar
NM_000059.3(BRCA2):c.-220G>T675BRCA2Conflicting interpretations of pathogenicity1036870835RCV001111445|RCV001111446|RCV001425606|RCV002259082|RCV002511042; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|M13328896243288962413:g.32889624G>T-
NM_000059.3(BRCA2):c.-210A>G675BRCA2Uncertain significance886050111RCV000290721|RCV000340931; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462133288963432889634NC_000013.10:g.32889634A>GClinGen:CA10634117C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.-175C>T675BRCA2Benign55880202RCV000191545|RCV000287128|RCV000502751|RCV000829446|RCV001514889|RCV002258824; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,M133288966932889669NC_000013.10:g.32889669C>TClinGen:CA276568C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.-52A>G675BRCA2Benign206118RCV000191546|RCV000297492|RCV000338379|RCV000585661|RCV001706165; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MedGen:CN169374|MedGen:C366190013328897923288979213:g.32889792A>GClinGen:CA276569C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.-40+2T>C675BRCA2Conflicting interpretations of pathogenicity1593879845RCV000797145|RCV002352335|RCV003330094; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213328898063288980613:g.32889806T>C-
NM_000059.4(BRCA2):c.-40+7G>T675BRCA2Conflicting interpretations of pathogenicity1555279969RCV000508126|RCV000581674|RCV000868731|RCV001113448|RCV001113449; NMedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:6125513328898113288981113:g.32889811G>TClinGen:CA645509353C0027672 Hereditary cancer-predisposing syndrome;
NM_000059.4(BRCA2):c.-26G>A675BRCA2Benign1799943RCV000112977|RCV000114981|RCV000246798|RCV000397056|RCV000580284|RCV001520600|RCV001705818; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480, Orphanet:227535|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C002767213328905723289057213:g.32890572G>ABreast Cancer Information Core (BIC) (BRCA2):203&base_change=G to A,ClinGen:CA016113C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.-11C>T675BRCA2Benign76874770RCV000113002|RCV000131010|RCV000175515|RCV000205927|RCV000370664|RCV001353870|RCV001705819|RCV003149775; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13328905873289058713:g.32890587C>TBreast Cancer Information Core (BIC) (BRCA2):218&base_change=C to T,ClinGen:CA011132C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.68-7T>A675BRCA2Benign81002830RCV000045051|RCV000074550|RCV000077384|RCV000168529|RCV000362403|RCV000579605|RCV000656581|RCV001353785|RCV001798237; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480, Orphanet:227535|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,Or13328932073289320713:g.32893207T>ABreast Cancer Information Core (BIC) (BRCA2):296-7&base_change=T to A,ClinGen:CA024538C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.179A>G (p.Asn60Ser)675BRCA2Conflicting interpretations of pathogenicity80358463RCV000031339|RCV000130469|RCV000168530|RCV001082266|RCV001114847|RCV001284556; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13328933253289332513:g.32893325A>GClinGen:CA013307C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.184T>C (p.Phe62Leu)675BRCA2Uncertain significance2072286770RCV001114849|RCV001114848; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213328933303289333013:g.32893330T>C-
NM_000059.4(BRCA2):c.198A>G (p.Gln66=)675BRCA2Benign28897700RCV000113265|RCV000162901|RCV000167850|RCV000377649|RCV000499809|RCV001353470|RCV001723632; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|M13328933443289334413:g.32893344A>GBreast Cancer Information Core (BIC) (BRCA2):426&base_change=A to G,ClinGen:CA014082C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.316G>A (p.Gly106Arg)675BRCA2Conflicting interpretations of pathogenicity786201916RCV000164444|RCV000637554|RCV001193279|RCV001729420|RCV003441762; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MedGen:C366190013328934623289346213:g.32893462G>AClinGen:CA017418C0677776 Hereditary breast and ovarian cancer syndrome;
NM_000059.4(BRCA2):c.316+13A>G675BRCA2Conflicting interpretations of pathogenicity773097109RCV000229296|RCV000378354|RCV000579746|RCV000586995|RCV000607980|RCV001094073|RCV001357840; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0012933,MedGen:C26133289347532893475NC_000013.10:g.32893475A>GClinGen:CA6940341C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.323A>G (p.Asn108Ser)675BRCA2Conflicting interpretations of pathogenicity80358568RCV000077298|RCV000166938|RCV000221445|RCV000315720|RCV001356621|RCV001372390|RCV002250509|RCV002267810; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO13328992193289921913:g.32899219A>GClinGen:CA017610C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.440A>G (p.Gln147Arg)675BRCA2Benign80358674RCV000044408|RCV000077324|RCV000120385|RCV000131281|RCV000349768|RCV000677867|RCV000679172|RCV001353994|RCV002250513|RCV003153335; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329002523290025213:g.32900252A>GClinGen:CA020118C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.506A>G (p.Lys169Arg)675BRCA2Conflicting interpretations of pathogenicity80358730RCV000031522|RCV000044547|RCV000074532|RCV000129126|RCV001111540|RCV001281705|RCV001798044; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329004093290040913:g.32900409A>GClinGen:CA021201C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.561G>A (p.Glu187=)675BRCA2Uncertain significance754678843RCV000296477|RCV000393185; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145133290068032900680NC_000013.10:g.32900680G>AClinGen:CA10644140C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.587G>T (p.Ser196Ile)675BRCA2Uncertain significance80358818RCV000044783|RCV000113840|RCV000166163|RCV000780031|RCV001111542|RCV003441732; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329007063290070613:g.32900706G>TClinGen:CA023332C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.608C>A (p.Thr203Asn)675BRCA2Conflicting interpretations of pathogenicity398122547RCV000076954|RCV000471187|RCV000509879|RCV000758918|RCV001113535; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329007273290072713:g.32900727C>AClinGen:CA023638C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.628A>G (p.Ile210Val)675BRCA2Uncertain significance1555281106RCV000690118|RCV001113537|RCV001113536|RCV002352134|RCV003327447; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|M13329007473290074713:g.32900747A>G-C0677776 Hereditary breast and ovarian cancer syndrome;
NM_000059.4(BRCA2):c.631+1G>A675BRCA2Pathogenic/Likely pathogenic81002897RCV000009942|RCV000044895|RCV000113913|RCV000131851|RCV000985563|RCV001310166; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|M13329007513290075113:g.32900751G>ABreast Cancer Information Core (BIC) (BRCA2):859+1&base_change=G to A,ClinGen:CA023848,OMIM:600185.0033C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.631+2T>G675BRCA2Pathogenic81002899RCV000009943|RCV000031615|RCV000044897|RCV000129071|RCV000195357|RCV000769680|RCV000826135|RCV001353557|RCV003147279; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C06777713329007523290075213:g.32900752T>GBreast Cancer Information Core (BIC) (BRCA2):859+2&base_change=T to G,ClinGen:CA023852,OMIM:600185.0034C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.632-3C>T675BRCA2Conflicting interpretations of pathogenicity568027879RCV001113538|RCV001113539|RCV001188038; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:14016213329035773290357713:g.32903577C>T-
NM_000059.4(BRCA2):c.658_659del (p.Val220fs)675BRCA2Pathogenic80359604RCV000009929|RCV000009930|RCV000009931|RCV000009932|RCV000031637|RCV000044988|RCV000074548|RCV000131858|RCV000210073|RCV000466729|RCV000735587|RCV001356991|RCV001843452|RCV002496316|RCV003128126|RCV003162226|RCV003335024|RCV003389667; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0008679,MedGen:CN033288,OMIM:194070, Orphanet:654|MONDO:MONDO:0013093,MedGen:C2751641,OMIM:613029, Orphanet:182067, Orphanet:360|Human Phenotype Ontology:HP:0002885,MONDO:MONDO:00013329036053290360613:g.32903605_32903606delBreast Cancer Information Core (BIC) (BRCA2):886&base_change=del GT,ClinGen:CA024188,OMIM:600185.0027C2676676 604370 Breast-ovarian cancer, familial 1;
NM_000059.4(BRCA2):c.658dup (p.Val220fs)675BRCA2Pathogenic-1RCV002285119; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213329036053290360632903605-
NM_000059.4(BRCA2):c.679G>A (p.Ala227Thr)675BRCA2Uncertain significance398122563RCV000076972|RCV000162816|RCV000467633|RCV000758934|RCV001113540|RCV003474658; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MedGen:C3661900|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329036273290362713:g.32903627G>AClinGen:CA024411C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.844C>G (p.His282Asp)675BRCA2Conflicting interpretations of pathogenicity768605944RCV001113541|RCV001114948|RCV003158428; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:14016213329064593290645913:g.32906459C>G-
NM_000059.4(BRCA2):c.847A>G (p.Ile283Val)675BRCA2Conflicting interpretations of pathogenicity80359097RCV000045529|RCV000077440|RCV000164639|RCV001114949|RCV001561218|RCV003235008; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|M13329064623290646213:g.32906462A>GClinGen:CA025663C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.865A>C (p.Asn289His)675BRCA2Benign766173RCV000034465|RCV000112858|RCV000120305|RCV000130996|RCV000351416|RCV000393165|RCV000470594|RCV000768559|RCV002496513; NMedGen:C3661900|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D0613213329064803290648013:g.32906480A>CClinGen:CA025765C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.909T>G (p.Ser303=)675BRCA2Likely benign757430441RCV000200243|RCV000215589|RCV000366189|RCV000495256|RCV001353837|RCV001711976|RCV002465558; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|M13329065243290652413:g.32906524T>GClinGen:CA339184C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.942A>G (p.Lys314=)675BRCA2Conflicting interpretations of pathogenicity1384322636RCV001019336|RCV001109311|RCV001114950|RCV002549502; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:14513329065573290655713:g.32906557A>G-
NM_000059.4(BRCA2):c.943T>A (p.Cys315Ser)675BRCA2Benign/Likely benign79483201RCV000045821|RCV000112866|RCV000130455|RCV000160200|RCV000402194|RCV000758976|RCV000769684|RCV002250498; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329065583290655813:g.32906558T>AClinGen:CA026159C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.1012G>A (p.Ala338Thr)675BRCA2Conflicting interpretations of pathogenicity80358396RCV000043719|RCV000112875|RCV000509731|RCV000759572|RCV001111640|RCV001280581; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329066273290662713:g.32906627G>AClinGen:CA010336C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.1114A>C (p.Asn372His)675BRCA2Benign144848RCV000009916|RCV000034427|RCV000120303|RCV000130720|RCV000207052|RCV000260146|RCV000320173|RCV000468776|RCV000768560|RCV002476952; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C1527349|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:00013329067293290672913:g.32906729A>CClinGen:CA010835,OMIM:600185.0013C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.1144A>C (p.Lys382Gln)675BRCA2Conflicting interpretations of pathogenicity371454630RCV000130560|RCV000195524|RCV000238792|RCV000500188|RCV001112103|RCV001170455|RCV001353620|RCV002227070; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329067593290675913:g.32906759A>CClinGen:CA010932C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.1166C>A (p.Pro389Gln)675BRCA2Benign397507263RCV000082883|RCV000129740|RCV000197010|RCV000294429|RCV000436893|RCV000587492|RCV000677855|RCV001353634; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|M13329067813290678113:g.32906781C>AClinGen:CA011014C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.1224G>A (p.Met408Ile)675BRCA2Conflicting interpretations of pathogenicity1593892275RCV001112105|RCV001112106|RCV003158427; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:14016213329068393290683913:g.32906839G>A-
NM_000059.4(BRCA2):c.1247T>G (p.Ile416Ser)675BRCA2Conflicting interpretations of pathogenicity80358418RCV000077253|RCV000129196|RCV001112107|RCV001284073|RCV001394892; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C06777713329068623290686213:g.32906862T>GClinGen:CA011324C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.1274A>G (p.Glu425Gly)675BRCA2Conflicting interpretations of pathogenicity768169574RCV000222738|RCV000701503|RCV001115060|RCV001115059; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:14513329068893290688913:g.32906889A>GClinGen:CA6940501C0677776 Hereditary breast and ovarian cancer syndrome;
NM_000059.4(BRCA2):c.1365A>G (p.Ser455=)675BRCA2Benign1801439RCV000112914|RCV000131025|RCV000173629|RCV000288642|RCV000387648|RCV000476213|RCV000656587; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C06777713329069803290698013:g.32906980A>GBreast Cancer Information Core (BIC) (BRCA2):1593&base_change=A to G,ClinGen:CA011778C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.1460C>A (p.Ala487Glu)675BRCA2Conflicting interpretations of pathogenicity56390402RCV000031322|RCV000131573|RCV000679155|RCV001082494|RCV001109419|RCV001818198; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329070753290707513:g.32907075C>AClinGen:CA012131C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.1762A>G (p.Asn588Asp)675BRCA2Conflicting interpretations of pathogenicity398122731RCV000077665|RCV000160207|RCV000163030|RCV000531905|RCV001109420|RCV001353480|RCV001703984; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329073773290737713:g.32907377A>GClinGen:CA013120C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.1788T>C (p.Asp596=)675BRCA2Benign11571642RCV000043883|RCV000112968|RCV000162709|RCV000173628|RCV000397994|RCV000462260|RCV000656589|RCV000770713|RCV001353850; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329074033290740313:g.32907403T>CBreast Cancer Information Core (BIC) (BRCA2):2016&base_change=T to C,ClinGen:CA013216C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.1813del (p.Ile605fs)675BRCA2Pathogenic80359306RCV000031344|RCV000043896|RCV000132177|RCV000203637|RCV001535574|RCV002272030|RCV003162267; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329074213290742113:g.32907421_32907421delBreast Cancer Information Core (BIC) (BRCA2):2034&base_change=del A,Breast Cancer Information Core (BIC) (BRCA2):2041&base_change=del A,ClinGen:CA013362C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.2229T>C (p.His743=)675BRCA2Benign1801499RCV000113024|RCV000130972|RCV000173973|RCV000333511|RCV000381055|RCV000462704|RCV000656591|RCV000755640; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C06777713329107213291072113:g.32910721T>CBreast Cancer Information Core (BIC) (BRCA2):2457&base_change=T to C,ClinGen:CA014685C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.2526A>G (p.Val842=)675BRCA2Likely benign770778164RCV000164822|RCV000384673|RCV000283169|RCV000495594|RCV001193281; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|M13329110183291101813:g.32911018A>GClinGen:CA015560C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.2538A>C (p.Ser846=)675BRCA2Benign11571654RCV000044011|RCV000113057|RCV000162905|RCV000167797|RCV000378892|RCV000656592|RCV001353445|RCV001798228; NMedGen:CN169374|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329110303291103013:g.32911030A>CBreast Cancer Information Core (BIC) (BRCA2):2766&base_change=A to C,ClinGen:CA015586C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.2550A>G (p.Gln850=)675BRCA2Benign/Likely benign80359785RCV000044014|RCV000113060|RCV000163041|RCV000286274|RCV000417797|RCV000679162|RCV000769688; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|M13329110423291104213:g.32911042A>GBreast Cancer Information Core (BIC) (BRCA2):2778&base_change=A to G,ClinGen:CA015617C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.2596G>A (p.Glu866Lys)675BRCA2Conflicting interpretations of pathogenicity864622476RCV000570600|RCV001109532|RCV001109533|RCV001867857; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145133291108832911088NC_000013.10:g.32911088G>AClinGen:CA387772620C0027672 Hereditary cancer-predisposing syndrome;
NM_000059.4(BRCA2):c.2606C>T (p.Ser869Leu)675BRCA2Conflicting interpretations of pathogenicity80358523RCV000113070|RCV000163028|RCV001109534|RCV001339978|RCV001357214; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|M13329110983291109813:g.32911098C>TClinGen:CA015810C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.2786T>C (p.Leu929Ser)675BRCA2Benign2227943RCV000077285|RCV000120345|RCV000162622|RCV000167848|RCV000299643|RCV000656593|RCV001353953|RCV003149672; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329112783291127813:g.32911278T>CClinGen:CA016363C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.2803G>A (p.Asp935Asn)675BRCA2Benign/Likely benign28897716RCV000044061|RCV000083092|RCV000120336|RCV000129118|RCV000397028|RCV000679163|RCV000768590|RCV001353683|RCV002496688; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329112953291129513:g.32911295G>AClinGen:CA016407C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.2883G>A (p.Gln961=)675BRCA2Benign11571655RCV000044081|RCV000113110|RCV000162529|RCV000168559|RCV000369425|RCV000585112|RCV000768591; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329113753291137513:g.32911375G>AClinGen:CA016678C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.2919G>A (p.Ser973=)675BRCA2Benign45525041RCV000044085|RCV000113113|RCV000162604|RCV000168560|RCV000308141|RCV000474196|RCV000586047|RCV000768592|RCV001358171; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329114113291141113:g.32911411G>AClinGen:CA016784C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.2960A>T (p.Asn987Ile)675BRCA2Benign2227944RCV000077289|RCV000120316|RCV000162623|RCV000167849|RCV000365242|RCV000656594|RCV001353508|RCV003149674; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329114523291145213:g.32911452A>TClinGen:CA016915C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.2987T>G (p.Leu996Arg)675BRCA2Benign80358545RCV000044098|RCV000113125|RCV000130463|RCV000167829|RCV000324539|RCV000679165; NMedGen:CN169374|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329114793291147913:g.32911479T>GClinGen:CA016971C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.3226G>A (p.Val1076Ile)675BRCA2Conflicting interpretations of pathogenicity431825304RCV000082909|RCV000222899|RCV000588617|RCV000799401|RCV001113630|RCV002247480; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329117183291171813:g.32911718G>AClinGen:CA017586C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.3264T>C (p.Pro1088=)675BRCA2Benign36060526RCV000044161|RCV000113152|RCV000152872|RCV000162497|RCV000372410|RCV000474724|RCV000656595|RCV000768626|RCV001353464|RCV002490603; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329117563291175613:g.32911756T>CClinGen:CA017665C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.3323A>C (p.Lys1108Thr)675BRCA2Conflicting interpretations of pathogenicity765232270RCV000637783|RCV003338700|RCV003157798; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:14016213329118153291181513:g.32911815A>CClinGen:CA6940687C0677776 Hereditary breast and ovarian cancer syndrome;
NM_000059.4(BRCA2):c.3396A>G (p.Lys1132=)675BRCA2Benign1801406RCV000114982|RCV000113170|RCV000130987|RCV000152873|RCV000337515|RCV000375777|RCV000656596; NMONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480, Orphanet:227535|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:60572413329118883291188813:g.32911888A>GClinGen:CA017926,Breast Cancer Information Core (BIC) (BRCA2):3624&base_change=A to GC2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.3415A>C (p.Lys1139Gln)675BRCA2Conflicting interpretations of pathogenicity747903103RCV000293210|RCV000350466|RCV003157506; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162133291190732911907NC_000013.10:g.32911907A>CClinGen:CA10643168C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.3447G>A (p.Met1149Ile)675BRCA2Conflicting interpretations of pathogenicity876660471RCV000221868|RCV000696715|RCV001109616|RCV001109617|RCV002478813|RCV003150129; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|M13329119393291193913:g.32911939G>AClinGen:CA10579578C0677776 Hereditary breast and ovarian cancer syndrome;
NM_000059.4(BRCA2):c.3495T>C (p.His1165=)675BRCA2Benign776655838RCV000167473|RCV000343589|RCV000395567|RCV000495612|RCV000604215; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|M13329119873291198713:g.32911987T>CClinGen:CA018171C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.3497T>A (p.Val1166Asp)675BRCA2Conflicting interpretations of pathogenicity762886975RCV000166339|RCV000309640|RCV000366646|RCV001094081|RCV001356826; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|M13329119893291198913:g.32911989T>AClinGen:CA018181C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.3516G>A (p.Ser1172=)675BRCA2Benign1799952RCV000044214|RCV000113188|RCV000162494|RCV000168565|RCV000268403|RCV000656597|RCV000768627|RCV002477145; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329120083291200813:g.32912008G>ABreast Cancer Information Core (BIC) (BRCA2):3744&base_change=G to A,ClinGen:CA018238C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.3807T>C (p.Val1269=)675BRCA2Benign543304RCV000130362|RCV000113220|RCV000152874|RCV000316398|RCV000354795|RCV000476701|RCV000656598; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329122993291229913:g.32912299T>CBreast Cancer Information Core (BIC) (BRCA2):4035&base_change=T to C,ClinGen:CA018842C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.3816G>C (p.Met1272Ile)675BRCA2Conflicting interpretations of pathogenicity1469541725RCV001220912|RCV001535557|RCV003158527; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145; MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:14016213329123083291230813:g.32912308G>C-
NM_000059.4(BRCA2):c.3824T>C (p.Ile1275Thr)675BRCA2Conflicting interpretations of pathogenicity80358625RCV000044272|RCV000083101|RCV000132466|RCV000985512|RCV001112374|RCV002271387; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329123163291231613:g.32912316T>CClinGen:CA018880C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.3869G>A (p.Cys1290Tyr)675BRCA2Benign41293485RCV000113233|RCV000120338|RCV000128895|RCV000167839|RCV000319921|RCV000467710|RCV000514107|RCV003149596; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329123613291236113:g.32912361G>AClinGen:CA019036C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.4068G>A (p.Leu1356=)675BRCA2Benign28897724RCV000044340|RCV000113269|RCV000162367|RCV000168569|RCV000385860|RCV000513194|RCV000768629|RCV001262741|RCV001353901; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329125603291256013:g.32912560G>ABreast Cancer Information Core (BIC) (BRCA2):4296&base_change=G to A,ClinGen:CA019458C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.4090A>C (p.Ile1364Leu)675BRCA2Benign56248502RCV000044344|RCV000113272|RCV000120319|RCV000131014|RCV000389513|RCV000469910|RCV000656601|RCV000770724; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329125823291258213:g.32912582A>CClinGen:CA019496C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.4241C>T (p.Thr1414Met)675BRCA2Benign70953664RCV000113286|RCV000120327|RCV000162766|RCV000167832|RCV000346290|RCV000656603|RCV001353946; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329127333291273313:g.32912733C>TClinGen:CA019759C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.4515_4525del (p.Phe1506fs)675BRCA2Pathogenic863224827RCV000199893|RCV000240973|RCV000575412|RCV001729453|RCV003474965; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|M133291300432913014NC_000013.10:g.32913007_32913017delClinGen:CA338948C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.4534C>T (p.Arg1512Cys)675BRCA2Conflicting interpretations of pathogenicity80358684RCV000044428|RCV000113312|RCV000130950|RCV000755874|RCV001113729|RCV003230379|RCV003153336; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329130263291302613:g.32913026C>TClinGen:CA020333C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.4563A>G (p.Leu1521=)675BRCA2Benign206075RCV000119245|RCV000132170|RCV000152875|RCV000257902|RCV000340564|RCV000461053|RCV000656604|RCV001354028; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329130553291305513:g.32913055A>GClinGen:CA020461C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.4584C>T (p.Ser1528=)675BRCA2Likely benign80359788RCV000044445|RCV000113323|RCV000123973|RCV000163135|RCV000305604|RCV000471202|RCV000679173|RCV000769693|RCV001353832; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329130763291307613:g.32913076C>TClinGen:CA020487C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.4631del (p.Asn1544fs)675BRCA2Pathogenic80359460RCV000031494|RCV000044455|RCV000130639|RCV000160290|RCV001535778|RCV003473178; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329131193291311913:g.32913119_32913119delBreast Cancer Information Core (BIC) (BRCA2):4859&base_change=del A,ClinGen:CA020560C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.4648G>T (p.Glu1550Ter)675BRCA2Pathogenic80358695RCV000009935|RCV000044460|RCV000113326|RCV000571951|RCV001530923|RCV003473074; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|M13329131403291314013:g.32913140G>TClinGen:CA020587,OMIM:600185.0029C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.4686A>G (p.Gln1562=)675BRCA2Likely benign28897730RCV000123977|RCV000162568|RCV000195757|RCV000299697|RCV000495537|RCV000585192|RCV000769697; NMedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:6125513329131783291317813:g.32913178A>GClinGen:CA020646C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.4733T>G (p.Leu1578Ter)675BRCA2Pathogenic/Likely pathogenic2137509604RCV001806374|RCV002541449; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:14513329132253291322532913225-
NM_000059.4(BRCA2):c.4787del (p.Asn1596fs)675BRCA2Pathogenic1593903422RCV000799227|RCV001028061; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213329132783291327813:g.32913278_32913278del-
NM_000059.4(BRCA2):c.4828G>A (p.Val1610Met)675BRCA2Conflicting interpretations of pathogenicity80358705RCV000031508|RCV000044498|RCV000074530|RCV000130783|RCV001112023|RCV001353552; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329133203291332013:g.32913320G>AClinGen:CA020880C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter)675BRCA2Pathogenic80358721RCV000031517|RCV000044533|RCV000128925|RCV000194794|RCV000195354|RCV000496311|RCV000762918|RCV000785221|RCV001269282|RCV001353669|RCV003473182; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462; MONDO:MONDO:0012933,MedGen:C2675520,OMIM:61255513329134573291345713:g.32913457C>GClinGen:CA021070C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.4991T>C (p.Ile1664Thr)675BRCA2Conflicting interpretations of pathogenicity863224590RCV000198889|RCV000571680|RCV001334182; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462133291348332913483NC_000013.10:g.32913483T>CClinGen:CA338267C0677776 Hereditary breast and ovarian cancer syndrome;
NM_000059.4(BRCA2):c.5199C>T (p.Ser1733=)675BRCA2Benign28897734RCV000044603|RCV000113396|RCV000152876|RCV000162368|RCV000277308|RCV000475668|RCV000488323|RCV000768598|RCV002477147; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329136913291369113:g.32913691C>TBreast Cancer Information Core (BIC) (BRCA2):5427&base_change=C to T,ClinGen:CA021671C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.5267T>A (p.Val1756Glu)675BRCA2Conflicting interpretations of pathogenicity770664957RCV000216072|RCV000985541|RCV001112466|RCV001112024|RCV001854705; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C06777713329137593291375913:g.32913759T>AClinGen:CA6940863C0027672 Hereditary cancer-predisposing syndrome;
NM_000059.4(BRCA2):c.5268A>G (p.Val1756=)675BRCA2Likely benign199879914RCV000122915|RCV000162513|RCV000329212|RCV000456829|RCV000495454|RCV000585978|RCV001175341; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480, Orphanet:2275313329137603291376013:g.32913760A>GClinGen:CA021893C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.5414A>G (p.Asn1805Ser)675BRCA2Conflicting interpretations of pathogenicity80358765RCV000113427|RCV000131487|RCV000590661|RCV000855580|RCV001112467|RCV001358175|RCV000044656; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0007254,MedGen:C00013329139063291390613:g.32913906A>GClinGen:CA022277C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.5418A>G (p.Glu1806=)675BRCA2Benign34351119RCV000119248|RCV000152877|RCV000162496|RCV000205532|RCV000278816|RCV000456283|RCV000656608|RCV000768630|RCV001353956|RCV002477303; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329139103291391013:g.32913910A>GClinGen:CA022290C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.5453C>A (p.Ser1818Ter)675BRCA2Pathogenic1566232471RCV000761285|RCV001024132; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162133291394532913945NC_000013.10:g.32913945C>A-
NM_000059.4(BRCA2):c.5576_5579del (p.Ile1859fs)675BRCA2Pathogenic80359520RCV000031556|RCV000044684|RCV000131118|RCV000160296|RCV000509336|RCV000735566|RCV001289538|RCV001353722|RCV003162273; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329140683291407113:g.32914066_32914069delBreast Cancer Information Core (BIC) (BRCA2):5803&base_change=del ATTA,Breast Cancer Information Core (BIC) (BRCA2):5804&base_change=del TTAA,ClinGen:CA0C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.5602G>A (p.Asp1868Asn)675BRCA2Conflicting interpretations of pathogenicity80358781RCV000509970|RCV000692500|RCV001113817|RCV001113818; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:14513329140943291409413:g.32914094G>AClinGen:CA387786063C0677776 Hereditary breast and ovarian cancer syndrome;
NM_000059.4(BRCA2):c.5604C>T (p.Asp1868=)675BRCA2Conflicting interpretations of pathogenicity1401654517RCV000774480|RCV001113819|RCV001113820|RCV001464209; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145133291409632914096NC_000013.10:g.32914096C>T-
NM_000059.4(BRCA2):c.5609_5610delinsAG (p.Phe1870Ter)675BRCA2Pathogenic276174859RCV000009924|RCV000044694|RCV000113449|RCV000129595|RCV000214770|RCV000255347|RCV001310124|RCV003473362; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|M133291410132914102NC_000013.10:g.32914101_32914102delinsAGClinGen:CA022697,OMIM:600185.0021C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.5635G>A (p.Glu1879Lys)675BRCA2Conflicting interpretations of pathogenicity55996097RCV000077357|RCV000129072|RCV000167807|RCV000168580|RCV000336386|RCV000755862; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329141273291412713:g.32914127G>AClinGen:CA022780C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.3(BRCA2):c.5704G>A (p.Asp1902Asn)675BRCA2Benign4987048RCV000113464|RCV000120340|RCV000131020|RCV000167833|RCV000314320|RCV000424920|RCV000462033|RCV000735573; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329141963291419613:g.32914196G>AClinGen:CA023014C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.5785A>G (p.Ile1929Val)675BRCA2Benign79538375RCV000031578|RCV000044755|RCV000162909|RCV000173974|RCV001110579|RCV001762065|RCV002490438|RCV003237416; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329142773291427713:g.32914277A>GClinGen:CA023228C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.5938A>C (p.Thr1980Pro)675BRCA2Conflicting interpretations of pathogenicity55877890RCV000531811|RCV000568300|RCV003447541; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462133291443032914430NC_000013.10:g.32914430A>CClinGen:CA6940915C0677776 Hereditary breast and ovarian cancer syndrome;
NM_000059.4(BRCA2):c.5946del (p.Ser1982fs)675BRCA2Pathogenic80359550RCV000009911|RCV000009910|RCV000009912|RCV000034451|RCV000044800|RCV000129627|RCV000212245|RCV000367838|RCV000414179|RCV000768632|RCV000785226|RCV001535431|RCV003128125; YMONDO:MONDO:0013235,MedGen:C3150546,OMIM:613347, Orphanet:1333|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MOND133291443832914438NC_000013.10:g.32914438delBreast Cancer Information Core (BIC) (BRCA2):6174&base_change=del T,ClinGen:CA023403,OMIM:600185.0005,OMIM:600185.0009CN239275 BRCA2-Related Disorders;
NM_000059.4(BRCA2):c.5986G>A (p.Ala1996Thr)675BRCA2Conflicting interpretations of pathogenicity80358833RCV000044813|RCV000077366|RCV000129689|RCV000195331|RCV000318984|RCV000859013; NMedGen:CN169374|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329144783291447813:g.32914478G>AClinGen:CA023455C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.6101G>A (p.Arg2034His)675BRCA2Conflicting interpretations of pathogenicity80358849RCV000083122|RCV000120341|RCV000166225|RCV001110580|RCV001529429|RCV001374119; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D0613213329145933291459313:g.32914593G>AClinGen:CA023655C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.6317T>C (p.Leu2106Pro)675BRCA2Conflicting interpretations of pathogenicity56172926RCV000044901|RCV000077370|RCV000131282|RCV001085349|RCV001112565|RCV001705700; NMedGen:CN169374|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329148093291480913:g.32914809T>CClinGen:CA023867C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.6347A>T (p.His2116Leu)675BRCA2Conflicting interpretations of pathogenicity55953736RCV000219720|RCV001071124|RCV001311839|RCV001535551; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145; MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,13329148393291483913:g.32914839A>TClinGen:CA10579690C0027672 Hereditary cancer-predisposing syndrome;
NM_000059.4(BRCA2):c.6513G>C (p.Val2171=)675BRCA2Benign206076RCV000119246|RCV000162377|RCV000152878|RCV000257903|RCV000261979|RCV000464673|RCV000656614|RCV001353926; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329150053291500513:g.32915005G>CClinGen:CA024126C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.6540G>C (p.Leu2180Phe)675BRCA2Conflicting interpretations of pathogenicity398122560RCV000076969|RCV000131800|RCV000160235|RCV000234409|RCV001109883; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329150323291503213:g.32915032G>CClinGen:CA024153C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.6713A>G (p.Asp2238Gly)675BRCA2Conflicting interpretations of pathogenicity80358895RCV000113631|RCV000130198|RCV000212251|RCV000656798|RCV001110667|RCV001351104; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D0613213329152053291520513:g.32915205A>GClinGen:CA024315C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.6785T>G (p.Met2262Arg)675BRCA2Conflicting interpretations of pathogenicity80358904RCV000077383|RCV000162802|RCV000225748|RCV001110668|RCV001284581|RCV001818218; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|M13329152773291527713:g.32915277T>GClinGen:CA024407C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.6886A>C (p.Ile2296Leu)675BRCA2Conflicting interpretations of pathogenicity576279166RCV000132216|RCV000203848|RCV000353391|RCV000410842|RCV000479638|RCV001284584; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|M13329187393291873913:g.32918739A>CClinGen:CA024540C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.6929C>A (p.Thr2310Asn)675BRCA2Uncertain significance276174886RCV000113672|RCV000487181|RCV000563131|RCV001322299|RCV003338397|RCV003319303; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329187823291878213:g.32918782C>AClinGen:CA024564C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.6935A>T (p.Asp2312Val)675BRCA2Benign80358916RCV000045088|RCV000113673|RCV000163021|RCV000243078|RCV000328837|RCV000586654|RCV002496694; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329187883291878813:g.32918788A>TClinGen:CA024570C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.7007G>A (p.Arg2336His)675BRCA2Pathogenic28897743RCV000009923|RCV000031659|RCV000045112|RCV000131031|RCV000174440|RCV000475925|RCV000735595|RCV001001799|RCV002496486; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|M13329210333292103313:g.32921033G>AOMIM:600185.0020,ClinGen:CA024713C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.7017G>C (p.Lys2339Asn)675BRCA2Benign45574331RCV000113692|RCV000120355|RCV000128918|RCV000167851|RCV000383466|RCV000465613|RCV000514662|RCV000768605|RCV001353904|RCV002504934; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329290073292900713:g.32929007G>CClinGen:CA024755C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.7034A>G (p.Gln2345Arg)675BRCA2Uncertain significance876661187RCV000222987|RCV001112648|RCV001112649; NMedGen:CN517202|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:14513329290243292902413:g.32929024A>GClinGen:CA10577488CN169374 not specified;
NM_000059.4(BRCA2):c.7052C>G (p.Ala2351Gly)675BRCA2Benign/Likely benign80358932RCV000031663|RCV000120352|RCV000131678|RCV000167842|RCV000343881|RCV000587020|RCV001353781|RCV001798052|RCV002250490; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329290423292904213:g.32929042C>GClinGen:CA024806C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.7057G>C (p.Gly2353Arg)675BRCA2Benign80358935RCV000113701|RCV000120356|RCV000130876|RCV000203630|RCV000294899|RCV000590450|RCV000735599; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O133292904732929047NC_000013.10:g.32929047G>CClinGen:CA024818C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.7104G>A (p.Leu2368=)675BRCA2Likely benign764698623RCV000495712|RCV000529923|RCV000567000|RCV001114004; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213329290943292909413:g.32929094G>AClinGen:CA6941059C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.7242A>G (p.Ser2414=)675BRCA2Benign1799955RCV000113739|RCV000152882|RCV000130994|RCV000336026|RCV000394273|RCV000474663|RCV000656617; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329292323292923213:g.32929232A>GBreast Cancer Information Core (BIC) (BRCA2):7470&base_change=A to G,ClinGen:CA024992C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.3(BRCA2):c.7435+10G>A675BRCA2Conflicting interpretations of pathogenicity81002793RCV000045210|RCV000113755|RCV000426181|RCV000302479|RCV000579409; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,O13329294353292943513:g.32929435G>ABreast Cancer Information Core (BIC) (BRCA2):7663+10&base_change=G to A,ClinGen:CA025078C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.7464_7465insTA (p.Asp2489Ter)675BRCA2Pathogenic886038169RCV000009921|RCV000241322; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:14513329305923293059313:g.32930592_32930593insATClinGen:CA10586575,OMIM:600185.0018C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.7464A>C (p.Arg2488Ser)675BRCA2Conflicting interpretations of pathogenicity80358969RCV000113764|RCV000164219|RCV000759655|RCV001110755|RCV001305633; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C06777713329305933293059313:g.32930593A>CClinGen:CA025098C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.7529T>C (p.Leu2510Pro)675BRCA2Pathogenic80358979RCV000009936|RCV000113772|RCV000478444|RCV000509658|RCV001290186; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C06777713329306583293065813:g.32930658T>CClinGen:CA025134,OMIM:600185.0030C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.7579del (p.Ala2526_Val2527insTer)675BRCA2Pathogenic1555286294RCV000584149|RCV000680273|RCV001860076; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:14513329307083293070813:g.32930708_32930708delClinGen:CA658683852C1838457 605724 Fanconi anemia, complementation group D1;
NM_000059.4(BRCA2):c.7806-14T>C675BRCA2Benign9534262RCV000132168|RCV000113823|RCV000152883|RCV000331967|RCV000386451|RCV000459462|RCV001811402|RCV001798289; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O133293664632936646NC_000013.10:g.32936646T>CBreast Cancer Information Core (BIC) (BRCA2):8034-14&base_change=T to C,ClinGen:CA025287C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.7976+12G>A675BRCA2Conflicting interpretations of pathogenicity81002827RCV000045362|RCV000113847|RCV000129688|RCV000195308|RCV000293235|RCV001353771; NMedGen:CN169374|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329368423293684213:g.32936842G>ABreast Cancer Information Core (BIC) (BRCA2):8204+12&base_change=G to A,ClinGen:CA025363C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.8113A>G (p.Ser2705Gly)675BRCA2Conflicting interpretations of pathogenicity756105620RCV000335958|RCV000586599|RCV000510067|RCV000530767|RCV001535652; NMedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462; MONDO:MONDO:0003582,MeSH:D061313329374523293745213:g.32937452A>GClinGen:CA6941189C0677776 Hereditary breast and ovarian cancer syndrome;
NM_000059.4(BRCA2):c.8154T>C (p.Ile2718=)675BRCA2Likely benign148880015RCV000124006|RCV000163230|RCV000411296|RCV001084044|RCV001114097; NMedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329374933293749313:g.32937493T>CClinGen:CA025474C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.8187G>T (p.Lys2729Asn)675BRCA2Benign80359065RCV000009925|RCV000045445|RCV000113885|RCV000120363|RCV000129090|RCV000735610|RCV001353739|RCV002250493; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,O13329375263293752613:g.32937526G>TClinGen:CA025498,OMIM:600185.0022C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.8215G>A (p.Val2739Ile)675BRCA2Conflicting interpretations of pathogenicity80359069RCV000045453|RCV000077431|RCV000129733|RCV000214196|RCV001110061|RCV001080912|RCV001353878|RCV003149693|RCV003421957; NMedGen:C3661900|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D0613213329375543293755413:g.32937554G>AClinGen:CA025521C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.8219T>A (p.Leu2740Ter)675BRCA2Pathogenic80359070RCV000009934|RCV000113889|RCV000236578|RCV001380789; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:14513329375583293755813:g.32937558T>AClinGen:CA025524,OMIM:600185.0028C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.8452G>T (p.Val2818Phe)675BRCA2Conflicting interpretations of pathogenicity80359094RCV000566230|RCV001320393|RCV001821668|RCV003227793|RCV003234782; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:61255133294465932944659NC_000013.10:g.32944659G>TClinGen:CA387752584C0027672 Hereditary cancer-predisposing syndrome;
NM_000059.4(BRCA2):c.8460A>C (p.Val2820=)675BRCA2Benign9590940RCV000045525|RCV000113937|RCV000128993|RCV000152884|RCV000404467|RCV000470439|RCV001711222|RCV002477152; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329446673294466713:g.32944667A>CClinGen:CA025653C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.8488-1G>A675BRCA2Pathogenic397507404RCV000009920|RCV000031747|RCV000160152|RCV000213906|RCV000231355|RCV000763329|RCV002221480|RCV003162283|RCV003473221; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C06777713329450923294509213:g.32945092G>AClinGen:CA025677,OMIM:600185.0017C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.8530G>A (p.Glu2844Lys)675BRCA2Conflicting interpretations of pathogenicity755783122RCV000215245|RCV000232530|RCV000307069|RCV000503308|RCV000662587; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0012933,MedGen13329451353294513513:g.32945135G>AClinGen:CA6941257C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.8732C>A (p.Ala2911Glu)675BRCA2Uncertain significance80359130RCV000009926|RCV003114180; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145133295090632950906NC_000013.10:g.32950906C>AClinGen:CA025796,OMIM:600185.0023C1838457 605724 Fanconi anemia, complementation group D1;
NM_000059.4(BRCA2):c.8825C>T (p.Ala2942Val)675BRCA2Conflicting interpretations of pathogenicity373227180RCV000130462|RCV000233879|RCV000356690|RCV000409083|RCV000780004|RCV001775622|RCV003390819; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|M13329535243295352413:g.32953524C>TClinGen:CA025840C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.8834A>G (p.Gln2945Arg)675BRCA2Uncertain significance587781800RCV000130065|RCV000410010|RCV000462799|RCV000487119|RCV001112819|RCV001193118; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MedGen:C3661900|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329535333295353313:g.32953533A>GClinGen:CA025844C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.8905G>A (p.Val2969Met)675BRCA2Benign59004709RCV000077456|RCV000163015|RCV000168609|RCV001080800|RCV001112821|RCV001353409|RCV001719798|RCV001798242; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329536043295360413:g.32953604G>AClinGen:CA025866C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.9082G>C (p.Ala3028Pro)675BRCA2Conflicting interpretations of pathogenicity80359161RCV000129295|RCV000114042|RCV000758971|RCV001055261|RCV001568367|RCV003460793; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329540153295401513:g.32954015G>CClinGen:CA025963C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.9106C>G (p.Gln3036Glu)675BRCA2Conflicting interpretations of pathogenicity202155613RCV000031795|RCV000074559|RCV000223314|RCV000289162|RCV000344086|RCV002250496|RCV002271381; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329540393295403913:g.32954039C>GClinGen:CA025983C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.9196C>T (p.Gln3066Ter)675BRCA2Pathogenic80359180RCV000009941|RCV000077463|RCV000131052|RCV000210196|RCV000235644|RCV000257912|RCV001357808|RCV003460449; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370, Orphanet:145|Me13329542223295422213:g.32954222C>TClinGen:CA026028,OMIM:600185.0032C2676676 604370 Breast-ovarian cancer, familial 1;
NM_000059.4(BRCA2):c.9246dup (p.Lys3083fs)675BRCA2Pathogenic886038189RCV000241025|RCV000460386|RCV000483716|RCV000569477|RCV003387517|RCV003463713; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329542713295427213:g.32954271_32954272insGClinGen:CA10586595C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.9433G>C (p.Val3145Leu)675BRCA2Conflicting interpretations of pathogenicity587776476RCV000129373|RCV000144220|RCV000499802|RCV001114170|RCV001088631|RCV001353675; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C06777713329690023296900213:g.32969002G>CClinGen:CA026155C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.9493A>G (p.Thr3165Ala)675BRCA2Conflicting interpretations of pathogenicity587782568RCV000131791|RCV000483383|RCV000657154|RCV001110138|RCV001110139|RCV001082356; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D0613213329690623296906213:g.32969062A>GClinGen:CA026176C0677776 Hereditary breast and ovarian cancer syndrome;
NM_000059.4(BRCA2):c.9502-12T>G675BRCA2Benign81002803RCV000045842|RCV000114123|RCV000131584|RCV000589086|RCV001110141|RCV001358665|RCV002272043; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329710233297102313:g.32971023T>GBreast Cancer Information Core (BIC) (BRCA2):9730-12&base_change=T to G,ClinGen:CA026188C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.9606G>A (p.Pro3202=)675BRCA2Likely benign755890067RCV000164400|RCV000460818|RCV000495294|RCV000504386|RCV001110896|RCV001087565; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0003582,MeSH:D0613213329711393297113913:g.32971139G>AClinGen:CA026230C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.9672dup (p.Tyr3225fs)675BRCA2Pathogenic80359773RCV000009922|RCV000114151|RCV000130631|RCV000197712|RCV000372727|RCV001353641|RCV003390793|RCV003460795; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|M13329723213297232213:g.32972321_32972322insAOMIM:600185.0019,Breast Cancer Information Core (BIC) (BRCA2):9900&base_change=ins A,ClinGen:CA026263C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.9693del (p.Leu3232fs)675BRCA2Pathogenic1566260827RCV000680274; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213329723433297234313:g.32972343_32972343del-C1838457 605724 Fanconi anemia, complementation group D1;
NM_000059.4(BRCA2):c.9760A>G (p.Lys3254Glu)675BRCA2Uncertain significance2073050616RCV001110898|RCV001110897; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213329724103297241013:g.32972410A>G-
NM_000059.4(BRCA2):c.9875C>T (p.Pro3292Leu)675BRCA2Benign56121817RCV000045908|RCV000077478|RCV000131346|RCV000195340|RCV000301085|RCV000513762|RCV001357526|RCV002250524; NMedGen:CN169374|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329725253297252513:g.32972525C>TClinGen:CA026319C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.10110G>A (p.Arg3370=)675BRCA2Benign28897762RCV000043713|RCV000112841|RCV000162524|RCV000168619|RCV000260989|RCV000464865|RCV000656626|RCV000768612; NMONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776, Orphanet:145|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,O13329727603297276013:g.32972760G>AClinGen:CA010263C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.*50A>G675BRCA2Uncertain significance761312704RCV000322262|RCV000376854; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462133297295732972957NC_000013.10:g.32972957A>GClinGen:CA6941496C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.*105A>C675BRCA2Benign15869RCV000112856|RCV000273093|RCV000585691|RCV001811401|RCV002319438; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:14016213329730123297301213:g.32973012A>CBreast Cancer Information Core (BIC) (BRCA2):10590&base_change=A to C,ClinGen:CA010709C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.*134C>T675BRCA2Uncertain significance1228334381RCV001110233|RCV001114254; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:14513329730413297304113:g.32973041C>T-
NM_000059.4(BRCA2):c.*172G>A675BRCA2Conflicting interpretations of pathogenicity574944914RCV000288738|RCV000382792|RCV002262972; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MedGen:C3661900133297307932973079NC_000013.10:g.32973079G>AClinGen:CA10634119C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.*248T>C675BRCA2Likely benign542356535RCV000350694|RCV000388870; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462133297315532973155NC_000013.10:g.32973155T>CClinGen:CA10644143C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.*271C>A675BRCA2Uncertain significance868342410RCV001110234|RCV001110235; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213329731783297317813:g.32973178C>A-
NM_000059.4(BRCA2):c.*292A>C675BRCA2Uncertain significance886050112RCV000292137|RCV000349435; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213329731993297319913:g.32973199A>CClinGen:CA10643170C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.*295C>G675BRCA2Benign11571834RCV000191871|RCV000297879; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462133297320232973202NC_000013.10:g.32973202C>GClinGen:CA276890C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.*369A>G675BRCA2Benign7334543RCV000191872|RCV000309611|RCV000585726|RCV002399709; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:14016213329732763297327613:g.32973276A>GClinGen:CA276891C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.*382A>G675BRCA2Likely benign559790882RCV000269374|RCV000366317; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213329732893297328913:g.32973289A>GClinGen:CA10639299C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.*390A>G675BRCA2Benign56003538RCV000191874|RCV000388239; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213329732973297329713:g.32973297A>GClinGen:CA276893C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.*397C>A675BRCA2Benign11571835RCV000191875|RCV000330314; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213329733043297330413:g.32973304C>AClinGen:CA276894C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.*399T>C675BRCA2Uncertain significance886050115RCV000281214|RCV000387262; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:14513329733063297330613:g.32973306T>CClinGen:CA10644151C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.*532A>G675BRCA2Benign11571836RCV000191876|RCV000341382|RCV001682902; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MedGen:C3661900133297343932973439NC_000013.10:g.32973439A>GClinGen:CA276895C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.*545T>C675BRCA2Uncertain significance536333595RCV000282839|RCV000403607; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:14513329734523297345213:g.32973452T>CClinGen:CA10643178C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.*623C>T675BRCA2Uncertain significance145550800RCV001114342|RCV001114341; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213329735303297353013:g.32973530C>T-
NM_000059.4(BRCA2):c.*696G>A675BRCA2Uncertain significance886050118RCV000310217|RCV000362569; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:14513329736033297360313:g.32973603G>AClinGen:CA10644171C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.*753C>T675BRCA2Uncertain significance190094748RCV000313810|RCV000397227; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:14513329736603297366013:g.32973660C>TClinGen:CA10634121C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.*839T>C675BRCA2Likely benign76358429RCV000331229|RCV000355634|RCV001311846; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MedGen:C366190013329737463297374613:g.32973746T>CClinGen:CA10639302C0015625 Fanconi anemia;
NM_000059.4(BRCA2):c.*841A>G675BRCA2Benign186619625RCV000254904|RCV000259887; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:31946213329737483297374813:g.32973748A>GClinGen:CA10588180C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.*842A>G675BRCA2Benign192347116RCV000254877|RCV000378951; NMONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462133297374932973749NC_000013.10:g.32973749A>GClinGen:CA10588181C2675520 612555 Breast-ovarian cancer, familial 2;
NM_000059.4(BRCA2):c.*854T>C675BRCA2Uncertain significance572993583RCV000321035|RCV000377946; NMONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724, Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555, Orphanet:14513329737613297376113:g.32973761T>CClinGen:CA10639306C0015625 Fanconi anemia;
MSeqDR Portal